cypher
1.In Cypher group,the above-mentioned index was 5(8.6%),2(3.4%).
2.Angiographic Follow-up Study after Cypher and Taxus DES Implantation in Coronary Artery Disease
3.Cypher(Cordis) and Taxus(Boston Scientific) stents are the major product in the market.
4.Angiographic pattern of restenosis following implantation of overlapping sirolimus-elu-ting (Cypher) stents
5.Spontaneous recanalization was observed in 76.47% in cypher DES, 63.16% in taxus stent group and 74.07% in BMS.
6.Results There was no difference of hs-CRP levels between Cypher stents group and bare stents group at different time(P >0.05).
7.Any side branches covered by the stents was evaluated. The results shows side branch occlusion occurred in 9.09% in cypher DES group , 10.50% in taxus DES group and 9.31% in BMS group.
8.Method This article summarized 157 patients in our department from Nov 2003 to Aug 2004. These patients were divided into two groups, the Cypher stent group and the Firebird stent group.
9.Conclusions The elevation of hs-CRP level at 8-hour and 24-hour after emergency PCI therapy operation is associated with one-year MACE in bare stents group,but not in Cypher stents group.
10.Methods 201 patients with 231 lesions were treated by using 243 rapamycin-eluting stents(Cypher, Cordis, a Johnson & Johnson Company) and 220 patients with 242 lesions by using 278 paclitaxel-eluting stents (Taxus, Boston Scientic).
